熱門資訊> 正文
RAPT Therapeutics宣布拟议公开募股
2025-10-22 04:17
- RAPT Therapeutics (NASDAQ:RAPT) announced on Tuesday that it has commenced an underwritten public offering of shares of its common stock.
- The company will grant the underwriters a 30-day purchase option of up to an additional 15% of the total number of common stock at the public offering price, less underwriting discounts and commissions.
More on RAPT Therapeutics
- RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria - Slideshow
- RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria Transcript
- RAPT Therapeutics jumps on mid-stage data for urticaria candidate
- Seeking Alpha’s Quant Rating on RAPT Therapeutics
- Historical earnings data for RAPT Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
